References
Been LB, Suurmeijer AJH, Cobben DCP, Jager PL, Hoekstra HJ, Elsinga PH. (18F)FLT-PET in oncology: current status and opportunities. Eur J Nucl Med Mol Imaging 2004;31:1659–72.
Christman D, Crawford EJ, Friedkin M, Wolf AP. Detection of DNA synthesis in intact organisms with positron-emitting (methyl-11C)thymidine. Proc Natl Acad Sci U S A 1972;69:988–92.
Visvikis D, Francis D, Mulligan R, Costa DC, Croasdale I, Luthra SK, et al. Comparison of methodologies for the in vivo assessment of 18FLT utilisation in colorectal cancer. Eur J Nucl Med Mol Imaging 2004;31:169–78.
Shields AF. PET Imaging with 8F-FDG and thymidine analogs: promise and pitfalls. J Nucl Med 2003;44:1432–4.
Krohn KA, Mankoff DA, Muzi M, Link JM, Spence AM. True tracers: comparing FDG with glucose and FLT with thymidine. Nucl Med Biol 2005;32:663–71.
Belt JA, Marina NM, Phelps DA, Crawford CR. Nucleoside transport in normal and neoplastic cells. Adv Enzyme Regul 1993;33:235–52.
Strauss LG, Klippel S, Pan L, Schönleben K, Haberkorn U, Dimitrakopoulou-Strauss A. Assessment of quantitative FDG PET data in primary colorectal tumours: which parameters are important with respect to tumour detection? Eur J Nucl Med Mol Imaging 2007;34:868–77.
Munch-Petersen B, Tyrsted G, Cloos L. Reversible ATP-dependent transition between two forms of human cytosolic thymidine kinase with different enzymatic properties. J Biol Chem 1993;268:15621–5.
Barthel H, Cleij MC, Collingridge DR, Hutchinson C, Osman S, He Q, et al. 3′-deoxy-3′-[18F]fluorothymidine as a new marker for monitoring tumor response to antiproliferative therapy in vivo with positron emission tomography. Cancer Res 2003;63:3791–8.
Lu L, Samuelsson L, Bergström M, Sato K, Fasth K-J, Langström B. Rat studies comparing 11C-FMAU, 18F-FLT, and 76Br-BFU as proliferation markers. J Nucl Med 2002;43:1688–98.
Quon A, Chang ST, Kamaya A, Dick DW, Loo BW Jr, Gambhir SS, et al. Pilot evaluation of 18F-fluorothymidine (FLT) PET/CT scanning for primary pancreatic cancer. Eur J Nucl Med Mol Imaging 2007; in press.
Seitz U, Wagner M, Neumaier, et al. Evaluation of pyrimidine metabolising enzymes and in vitro uptake of 3′-[(18)F]fluoro-3′-deoxythymidine ([(18)F]FLT) in pancreatic cancer cell lines. Eur J Nucl Med Mol Imaging 2002;9:1174–81.
Choi SJ, Kim JS, Kim JH, Oh SJ, Lee JG, Kim CJ, et al. 18F]3′-deoxy-3′-fluorothymidine PET for the diagnosis and grading of brain tumors. Eur J Nucl Med Mol Imaging 2005;32:653–9.
Cobben DCP, Elsinga PH, Suurmeijer AJH, Vaalburg W, Maas B, Jager PL, et al. Detection and grading of soft tissue sarcomas of the extremities with (18)F-3′-fluoro-3′-deoxy-l-thymidine. Clin Cancer Res 2004;10:1685–90.
Buchmann I, Neumaier B, Schreckenberger M, Reske S. 18F]3′-deoxy-3′-fluorothymidine-PET in NHL patients: whole-body biodistribution and imaging of lymphoma manifestations—a pilot study. Cancer Biother Radiopharm 2004;19:436–42.
Dittman H, Dohmen BM, Paulsen F, Eichhorn K, Eschmann SM, Horger M, et al. (18F)FLT PET for diagnosis and staging of thoracic tumors. Eur J Nucl Med Mol Imaging 2003;30:1407–12.
Buck AK, Hetzel M, Schirrmeister H, Halter G, Möller P, Kratochwill C, et al. Clinical relevance of imaging proliferative activity in lung nodules. Eur J Nucl Med Mol Imaging 2005;32:525–33.
Been LB, Elsinga PH, deVries J, Cobben DCP, Jager PL, et al. Positron emission tomography in patients with breast cancer using (18)F-3′-deoxy-3′-fluoro-l-thymidine ((18)F-FLT)—a pilot study. Eur J Surg Oncol 2006;32:39–43.
Francis DL, Visvikis D, Costa DC, Arulampalam TH, Townsend C, Luthra SK, et al. Potential impact of [18F]3′-deoxy-3′-fluorothymidine versus [18F]fluoro-2-deoxy-d-glucose in positron emission tomography for colorectal cancer. Eur J Nucl Med Mol Imaging 2003;30:988–94.
Leyton J, Latigo JR, Perumal M, Dhaliwal H, He Q, Aboagye EO. Early detection of tumor response to chemotherapy by 3′-deoxy-3′-[18F]fluorothymidine positron emission tomography: the effect of cisplatin on a fibrosarcoma tumor model in vivo. Cancer Res 2005;65:4202–10.
Author information
Authors and Affiliations
Corresponding author
Additional information
This Editorial commentary refers to the article http://dx.doi.org/10.1007/s00259-007-0630-z.
Rights and permissions
About this article
Cite this article
Dimitrakopoulou-Strauss, A., Strauss, L.G. The role of 18F-FLT in cancer imaging: does it really reflect proliferation?. Eur J Nucl Med Mol Imaging 35, 523–526 (2008). https://doi.org/10.1007/s00259-007-0679-8
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00259-007-0679-8